Dr Fidler speaks with ecancer at NOSCM 2017 about treating brain and central nervous system cancers with EGFR and ALK mutations. She describes how results from small phase I trials are providing useful insights into rare or relapsed diseases, and...
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2h2rHu3
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου